ORAL BCG VACCINE IN CROHNS-DISEASE

被引：31

作者：

BURNHAM, WR

LENNARDJONES, JE

HECKETSWEILER, P

COLIN, R

GEFFROY, Y

机构：

[1] ST MARKS HOSP,LONDON EC1V 2PS,ENGLAND

[2] HOP CHARLES NICOLLE,F-76038 ROUEN,FRANCE

来源：

GUT | 1979年 / 20卷 / 03期

关键词：

D O I：

10.1136/gut.20.3.229

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

In a randomized double-blind trial over one year oral BCG has been compared with a control preparation in the treatment of chronic Crohn's disease. Overall assessment scores deteriorated in 9 of 22 patients taking BCG, and 11 of 26 in the control group (P = 0.25); this deterioration was great enough to be regarded as a clinical relapse in three patients taking BCG and in seven taking the control preparation (P > 0.1). No significant benefit from oral BCG treatment has been demonstrated.

引用

页码：229 / 233

页数：5

共 15 条

[1]

BEST WR, 1976, GASTROENTEROLOGY, V70, P439

[2]

GEFFROY Y, 1977, ANN GASTROENT HEPATO, V13, P317

[3]

KLEIN M, 1974, GASTROENTEROLOGY, V66, P916

[4]

LENNARDJONES JE, 1971, REGIONAL ENTERITIS C, P105

[5] IMMUNOPOTENTIATION WITH BCG .1. IMMUNE-RESPONSE TO DIFFERENT STRAINS AND PREPARATIONS [J].

MACKANESS, GB ;

AUCLAIR, DJ ;

LAGRANGE, PH .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1973, 51 (05) :1655-1667

[6]

MANDE R, 1968, BCG VACCINATION

[7] CELL-MEDIATED-IMMUNITY AND TRANSFER-FACTOR IN CROHNS-DISEASE [J].

NG, RP ;

VICARY, FR .

BRITISH MEDICAL JOURNAL, 1976, 2 (6027) :87-88

[8] DOUBLE-BLIND WITHDRAWAL TRIAL OF AZATHIOPRINE AS MAINTENANCE TREATMENT FOR CROHNS-DISEASE [J].

ODONOGHUE, DP ;

DAWSON, AM ;

POWELLTUCK, J ;

BOWN, RL ;

LENNARDJONES, JE .

LANCET, 1978, 2 (8097) :955-957

[9]

RHODES J, 1971, LANCET, V2, P1273

[10] CONTROLLED TRIAL OF AZATHIOPRINE IN CROHNS-DISEASE [J].

ROSENBERG, JL ;

LEVIN, B ;

WALL, AJ ;

KIRSNER, JB .

AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1975, 20 (08) :721-726

← 1 2 →